CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member] Series S Units [Member]	Common Stock [Member] Class B Profit Interests [Member]	Additional Paid In Capital [Member]	Additional Paid In Capital [Member] Series S Units [Member]	Additional Paid In Capital [Member] Class B Profit Interests [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Total	Series S Units [Member]	Class B Profit Interests [Member]
Balance at Dec. 31, 2019	$ 0	$ 7,714			$ 1,000,097			$ 0	$ (1,288,842)	$ (281,031)
Balance (in shares) at Dec. 31, 2019	0	7,713,528
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Units			$ 5,316			$ 3,310,384					$ 3,315,700
Issuance of Units (in shares)			5,316,284
Conversion of Promissory notes for MOR Series S Units in March 2020			$ 296			$ 184,005					$ 184,300
Conversion of Promissory notes for MOR Series S Units in March 2020 (in shares)			295,501
Vested Units				$ 329			$ 4,899					$ 5,228
Vested Units (in shares)				329,438
Net loss									(675,136)	(675,136)
Foreign currency translation										0
Balance at Mar. 31, 2020	$ 0	$ 13,655			4,499,384			0	(1,963,978)	2,549,061
Balance (in shares) at Mar. 31, 2020	0	13,654,750
Balance at Dec. 31, 2020	$ 0	$ 21,233			17,514,907			0	(6,269,025)	11,267,115
Balance (in shares) at Dec. 31, 2020	0	21,233,039
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Forian Common stock in Helix Acquisition		$ 8,408			18,446,376					18,454,784
Issuance of Forian Common stock in Helix Acquisition (in shares)		8,408,383
Forian Restricted Stock Vesting from MOR unvested restricted stock		$ 173			2,570					2,743
Forian Restricted Stock Vesting from MOR unvested restricted stock (in shares)		172,835
Forian shares issued upon exercise of MOR Class B options		$ 10			292,820					292,830
Forian shares issued upon exercise of MOR Class B options (in shares)		10,167
Net loss									(4,491,647)	(4,491,647)
Stock based compensation expense					863,883					863,883
Issuance of common stock warrants					389,976					389,976
Foreign currency translation								(24,006)		(24,006)
Balance at Mar. 31, 2021	$ 0	$ 29,824			$ 37,510,532			$ (24,006)	$ (10,760,672)	$ 26,755,678
Balance (in shares) at Mar. 31, 2021	0	29,824,424